Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists. - Wikidata - awgldk - TriplyDB

Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists.

Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists.

http://www.wikidata.org/entity/Q37063800

about

Prostanoid receptor EP2 as a therapeutic target Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus EP2 Receptor Signaling Regulates Microglia Death.Evaluation of WO 2012/177618 A1 and US-2014/0179750 A1: novel small molecule antagonists of prostaglandin-E2 receptor EP2.Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside Defining the therapeutic time window for suppressing the inflammatory prostaglandin E2 signaling after status epilepticus.Cyclooxygenase-2 in glioblastoma multiforme.Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype.

P2860

Q33711678-67D2F40E-066B-461B-A9F6-6140FD8EE2F1 Q35534894-84C92A59-2C30-4092-B953-0B3A88B1A1A9 Q35745955-C442DC34-28D1-43C8-B457-5C7FAE648352 Q36833728-093D613C-A4A3-4387-8C61-6DED46E4C495 Q37340703-24B5B82C-CF27-4C4B-96B4-9AC4FAB12470 Q37350938-0B59EB09-6F4D-4285-848D-8DE1A2A9BFF0 Q38969912-FB689EDE-BC33-45FF-9D14-DE6FAE724427 Q41533962-E6B01C53-049C-4A87-BFE8-5FF666DACC82

P2860

Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists.

http://www.wikidata.org/entity/Q37063800

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists.

@en

Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists.

@nl

type

label

Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists.

@en

Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists.

@nl

prefLabel

Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists.

@en

Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists.

@nl

P1433

Q37063800-47AE14D4-4534-4E8C-9B89-F714A4024E06

P1476

Q37063800-E517BD35-941A-401E-8C49-0D90C71E755B

P2093

Q37063800-2CA79E70-9E32-45C4-8447-7CB50FC0015E

Q37063800-ACB77E86-B8D6-401F-AB04-5523D7D8778E

P2860

Q37063800-02905FD0-9F9D-43B2-9709-B4DB514B7729

Q37063800-0B2BCFBA-E0ED-4A9B-8A8B-210270D30F5C

Q37063800-1A896B30-5C7F-4693-9C37-D141607BF5DF

Q37063800-2F3A5CC8-296E-4DCE-A024-7342C1D1D7FE

Q37063800-3AED4E2C-CC8A-4303-8D20-56DD8A4E2ED8

Q37063800-4C21A51A-7E46-4AC2-9833-A55AF44C94E4

Q37063800-4C96AEE4-582E-45DC-A831-E281666C3226

Q37063800-64F8C011-6EEC-4EC3-8423-1B8864964529

Q37063800-78C86253-1B28-44AA-BFF8-3CD99A594F12

Q37063800-7B09BCDA-AD87-45DC-965B-1E9F6EC48778

P304

Q37063800-7B71E5AC-A7B1-4E7C-AE8C-2EC77A68D213

P31

Q37063800-9D5CA595-CB7F-46A7-A868-5C8B57F5C155

P356

Q37063800-4A040BFC-D8F2-415E-A27C-6B530A145251

P433

Q37063800-DA237D0B-460B-4EEB-A102-20BCAF210744

P478

Q37063800-EF2B0CD4-9D0D-4726-B60B-92BB30DCCA00

P50

Q37063800-17688A36-4817-4726-B809-551966AAFEBB

Q37063800-F20B85E3-44CD-4292-ABF7-4952AE0D6AB7

P577

Q37063800-0FC9999D-630D-44EA-80C4-463CADCF16C0

P698

Q37063800-C4162B2F-675B-4A5D-AE9D-0A70CD114571

P932

Q37063800-28D11804-639F-4172-A590-4B387BF7A7E8

P356

P1433

ACS Medicinal Chemistry Letters

P1476

Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists

@en

P2093

Rangaiah Shashidharamurthy

http://www.w3.org/2001/XMLSchema#string

Thota Ganesh

http://www.w3.org/2001/XMLSchema#string

P2860

Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP

Inflammation and Alzheimer's disease

The pathogenesis of rheumatoid arthritis

Prostanoid receptors: structures, properties, and functions

A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates.

Inflammatory bowel disease: cause and immunobiology.

Robust and systematic drug screening method using chemical arrays and the protein library: identification of novel inhibitors of carbonic anhydrase II.

Cox-2-selective inhibitors: the new super aspirins.

Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor.

Emerging roles of PGE2 receptors in models of neurological disease.

P304

616-621

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ML400112H

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Jianxiong Jiang

Raymond Dingledine

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23914286

http://www.w3.org/2001/XMLSchema#string

P932

3731160

http://www.w3.org/2001/XMLSchema#string